Clinical Trial Update: BMS-247550 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating BMS-247550 for prostate cancer that progressed after hormone therapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• BMS-247550

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED